## Correct Answer: D. Scleromalacia perforans Scleromalacia perforans is a severe ocular manifestation of rheumatoid arthritis (RA), representing the most advanced form of scleritis. In RA, immune-mediated inflammation targets the sclera, causing progressive necrosis and thinning. Unlike simple scleritis (which presents with pain and redness), scleromalacia perforans is a painless, progressive condition where the sclera becomes thin, translucent, and eventually perforates—exposing the underlying uvea (hence the dark appearance clinically). This occurs due to vasculitis of the episcleral and scleral vessels, leading to ischemic necrosis. The condition is part of the spectrum of RA-associated ocular complications (along with episcleritis, scleritis, and keratitis). Scleromalacia perforans represents end-stage scleral disease and carries high risk of blindness if untreated. It is a classic association with systemic autoimmune diseases, particularly RA, and is a hallmark finding that should immediately prompt investigation for underlying systemic disease. The diagnosis is clinical (thin, translucent sclera with dark uveal show-through) and requires urgent systemic immunosuppression and ophthalmologic management to prevent perforation and vision loss. ## Why the other options are wrong **A. Coloboma** — Coloboma is a congenital developmental defect of the eye (failure of the optic fissure to close), not an acquired inflammatory complication of RA. It presents as a notch or cleft in the iris, ciliary body, retina, or optic nerve—none of which are related to RA-induced vasculitis or scleral inflammation. This is a classic NBE trap pairing ocular pathology with systemic disease without causal link. **B. Malignant melanoma** — Malignant melanoma is a neoplastic condition of melanocytes (uveal or conjunctival origin), not an inflammatory complication of RA. While RA patients may develop malignancies due to chronic immunosuppression, melanoma is not a direct manifestation of RA-induced vasculitis. This option exploits confusion between 'ocular complications' and 'systemic disease complications.' **C. Ciliary staphyloma** — Ciliary staphyloma is a localized bulging of the ciliary body, typically secondary to chronic inflammation (e.g., chronic uveitis) or high myopia, not a primary manifestation of RA scleritis. While staphylomas can occur in advanced uveitis, scleromalacia perforans (scleral thinning with uveal show-through) is the pathognomonic RA-associated finding. This option confuses staphyloma (bulging) with scleromalacia (thinning). ## High-Yield Facts - **Scleromalacia perforans** is the most severe form of scleritis, characterized by painless progressive scleral necrosis and thinning in RA patients. - **RA-associated ocular manifestations** follow a spectrum: episcleritis (mild) → scleritis (moderate) → scleromalacia perforans (severe, sight-threatening). - **Vasculitis of episcleral and scleral vessels** causes ischemic necrosis in scleromalacia, leading to dark uveal show-through (pathognomonic sign). - **Scleromalacia perforans is painless** (unlike acute scleritis), making it insidious and often diagnosed late—a key clinical pearl for exam questions. - **Management requires urgent systemic immunosuppression** (DMARDs, biologics) plus ophthalmologic care to prevent perforation and blindness in Indian RA cohorts. ## Mnemonics **RA Ocular Spectrum (SCARE)** **S**cleritis → **C**iliary involvement → **A**nterior uveitis → **R**etinal vasculitis → **E**piscleritis (reverse order of severity). Scleromalacia is end-stage scleritis. **Scleromalacia = Thin + Dark + Painless** **Thin** sclera (ischemic necrosis), **Dark** uveal show-through (pathognomonic), **Painless** (unlike acute scleritis). Use this triad to spot it on images. ## NBE Trap NBE pairs ocular pathology terms (coloboma, staphyloma, melanoma) with RA to test whether students know the *specific* RA-associated scleral complication. The trap is confusing congenital (coloboma), neoplastic (melanoma), or other inflammatory (staphyloma) conditions with RA-induced vasculitic scleromalacia. ## Clinical Pearl In Indian RA cohorts, scleromalacia perforans often goes undiagnosed until late because patients present with painless vision loss, not pain. Always examine the sclera in RA patients during routine clinic visits—early detection and aggressive DMARDs (methotrexate, biologics) can prevent blindness, a major cause of disability in Indian RA populations. _Reference: Robbins Ch. 15 (Systemic Diseases and the Eye); Harrison Ch. 333 (Rheumatoid Arthritis); Bailey & Love Ch. 26 (Ophthalmology)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.